A critical advance in cancer research is emerging with the use of nanobodies to re-engage dysfunctional p53. This vital malignant protector protein is frequently disabled in many types of cancer, resulting uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research